{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T20:47:09Z","timestamp":1776113229203,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100031251","name":"College of Medicine, University of Arkansas for Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031251","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.neuroscience.2026.03.020","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:41:18Z","timestamp":1773852078000},"page":"104-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Impact of P-glycoprotein substrates on transendothelial transport of amyloid-\u03b2 peptide in an in vitro model"],"prefix":"10.1016","volume":"602","author":[{"suffix":"Jr","given":"Joseph","family":"Asante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6049-6480","authenticated-orcid":false,"given":"Steven W.","family":"Barger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2026.03.020_b0005","doi-asserted-by":"crossref","DOI":"10.1177\/13872877251351629","article-title":"Prescription-based association of P-glycoprotein substrates with Alzheimer\u2019s disease risk: a nested case-control study","author":"Asante","year":"2025","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0010","doi-asserted-by":"crossref","DOI":"10.1080\/17590914.2025.2495632","article-title":"P-glycoprotein and Alzheimer's disease: threats and opportunities","volume":"17","author":"Asante","year":"2025","journal-title":"ASN Neuro"},{"key":"10.1016\/j.neuroscience.2026.03.020_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.1065193","article-title":"A human-derived neurovascular unit in vitro model to study the effects of cellular cross-talk and soluble factors on barrier integrity","volume":"16","author":"Barberio","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0020","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","article-title":"Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system","volume":"27","author":"Bell","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0025","doi-asserted-by":"crossref","first-page":"823","DOI":"10.4140\/TCP.n.2014.823","article-title":"Mirabegron: a beta-3 agonist for overactive bladder","volume":"29","author":"Bragg","year":"2014","journal-title":"Consult. Pharm."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0030","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrd2368","article-title":"Modelling of the blood-brain barrier in drug discovery and development","volume":"6","author":"Cecchelli","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0035","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/j.neurobiolaging.2015.05.020","article-title":"P-glycoprotein expression and amyloid accumulation in human aging and Alzheimer's disease: preliminary observations","volume":"36","author":"Chiu","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuroscience.2026.03.020_b0040","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI25247","article-title":"P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model","volume":"115","author":"Cirrito","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0045","doi-asserted-by":"crossref","first-page":"e1316","DOI":"10.1002\/wcms.1316","article-title":"About P-glycoprotein: a new drugable domain is emerging from structural data","volume":"7","author":"Ferreira","year":"2017","journal-title":"WIREs Comput. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0050","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1021\/ci400195v","article-title":"Molecular docking characterizes substrate-binding sites and efflux modulation mechanisms within P-glycoprotein","volume":"53","author":"Ferreira","year":"2013","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0055","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/01.CIR.99.4.552","article-title":"Inhibition of P-glycoprotein-mediated drug transport: a unifying mechanism to explain the interaction between digoxin and quinidine [seecomments]","volume":"99","author":"Fromm","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.neuroscience.2026.03.020_b0060","first-page":"287","article-title":"Understanding the physiology of the blood-brain barrier: in vitro models","volume":"13","author":"Grant","year":"1998","journal-title":"News Physiol. Sci."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0065","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s13318-016-0350-5","article-title":"Pharmacokinetic interactions between mirabegron and metformin, warfarin, digoxin or combined oral contraceptives","volume":"42","author":"Groen-Wijnberg","year":"2017","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0070","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2026.03.020_b0075","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1124\/mol.109.061754","article-title":"Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease","volume":"77","author":"Hartz","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0080","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1023\/B:PHAM.0000041466.84653.8c","article-title":"Interactions of human P-glycoprotein with simvastatin, simvastatin acid, and atorvastatin","volume":"21","author":"Hochman","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0085","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","article-title":"The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics","volume":"21","author":"Karran","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0090","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nrm3810","article-title":"The amyloid state and its association with protein misfolding diseases","volume":"15","author":"Knowles","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0095","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1172\/JCI57867","article-title":"Cerebral amyloid-beta proteostasis is regulated by the membrane transport protein ABCC1 in mice","volume":"121","author":"Krohn","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0100","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1124\/dmd.111.038075","article-title":"Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs","volume":"39","author":"Li","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0105","doi-asserted-by":"crossref","first-page":"17082","DOI":"10.1016\/S0021-9258(18)41896-0","article-title":"Mass spectrometry of purified amyloid beta protein in Alzheimer's disease","volume":"267","author":"Mori","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0110","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00210-001-0489-7","article-title":"Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoprotein","volume":"364","author":"Pauli-Magnus","year":"2001","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0115","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1021\/pr050475v","article-title":"Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry","volume":"5","author":"Portelius","year":"2006","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0120","doi-asserted-by":"crossref","first-page":"6505","DOI":"10.1021\/ja1117123","article-title":"A\u03b240 and A\u03b242 amyloid fibrils exhibit distinct molecular recycling properties","volume":"133","author":"S\u00e1nchez","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0125","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1432-1033.1997.00130.x","article-title":"Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities","volume":"250","author":"Shapiro","year":"1997","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbi.2018.07.017","article-title":"The concerted amyloid-beta clearance of LRP1 and ABCB1\/P-gp across the blood-brain barrier is linked by PICALM","volume":"73","author":"Storck","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0135","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0376-22.2023","article-title":"Amyloid beta-peptide effects on glucose regulation are dependent on apolipoprotein E genotype","volume":"10","author":"Sung","year":"2023","journal-title":"eNeuro"},{"key":"10.1016\/j.neuroscience.2026.03.020_b0140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0145","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/jcbfm.2009.42","article-title":"P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta","volume":"29","author":"Tai","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0150","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1073\/pnas.1910444117","article-title":"Proteome-wide observation of the phenomenon of life on the edge of solubility","volume":"117","author":"Vecchi","year":"2020","journal-title":"PNAS"},{"key":"10.1016\/j.neuroscience.2026.03.020_b0155","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2174\/1567205013666160314151012","article-title":"A role for P-glycoprotein in clearance of Alzheimer amyloid \u03b2 -peptide from the brain","volume":"13","author":"Wang","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0160","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3389\/fcell.2020.00768","article-title":"Dynamic blood concentrations of A\u03b2(1-40) and A\u03b2(1-42) in Alzheimer's disease","volume":"8","author":"Yang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.neuroscience.2026.03.020_b0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2016.07.007","article-title":"The blood-brain barrier in Alzheimer's disease","volume":"107","author":"Zenaro","year":"2017","journal-title":"Neurobiol. Dis."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226001946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452226001946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T19:34:07Z","timestamp":1776108847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452226001946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":33,"alternative-id":["S0306452226001946"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.03.020","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of P-glycoprotein substrates on transendothelial transport of amyloid-\u03b2 peptide in an in vitro model","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of International Brain Research Organization (IBRO).","name":"copyright","label":"Copyright"}]}}